Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Iodophenpropit is a histamine H3 receptor antagonist (pA2 = 9.6 in guinea pig intestine, which has a high endogenous expression of H3 receptors).1 It increases forskolin-induced cAMP production in SK-N-MC cells expressing the recombinant human H3 receptor (EC50 = 25.1 nM).2 It is also an inhibitor of NR1/NR2A, NR1/NR2B, NR1/NR2C, and NR1/NR2D subunit-containing NMDA receptors (IC50s = 1.3, 1.4, 9.7, and 14 µM, respectively, for the rat recombinant receptors).3 Iodophenpropit induces scratching behavior in mice when administered intradermally at a dose of 10 nmol and reduces amygdala-kindled seizure duration in rats (ED50 = 2.54 mg/kg).4,5
WARNING This product is not for human or veterinary use.
1. Characterization of the binding of the first selective radiolabelled histamine H3-
2. Constitutive activity of histamine H3 receptors stably expressed in SK-
3. Implementation of a fluorescence-
4. Role of substance P on histamine H3 antagonist-
5. Inhibitory effect of iodophenpropit, a selective histamine H3 antagonist, on amygdaloid kindled seizures. Brain Res. Bull. 63(2), 143-146 (2004).